Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Cory Kasimov is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/12/2025 | SMMT | Buy Now | Summit Therapeutics | $19.85 | 51.13% | Cory Kasimov70% | → $30 | Initiates | → Outperform | Get Alert |
| 02/12/2025 | SWTX | Buy Now | SpringWorks Therapeutics | $49.65 | 30.92% | Cory Kasimov70% | $60 → $65 | Maintains | Outperform | Get Alert |
| 01/27/2025 | MRNA | Buy Now | Moderna | $33.73 | 48.24% | Cory Kasimov70% | $60 → $50 | Maintains | In-Line | Get Alert |
| 12/23/2024 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 58.73% | Cory Kasimov70% | $45 → $50 | Maintains | Outperform | Get Alert |
| 12/17/2024 | EWTX | Buy Now | Edgewise Therapeutics | $26.53 | 88.47% | Cory Kasimov70% | $45 → $50 | Maintains | Outperform | Get Alert |
| 11/22/2024 | EWTX | Buy Now | Edgewise Therapeutics | $26.53 | 69.62% | Cory Kasimov70% | → $45 | Initiates | → Outperform | Get Alert |
| 11/20/2024 | SWTX | Buy Now | SpringWorks Therapeutics | $49.65 | 20.85% | Cory Kasimov70% | → $60 | Initiates | → Outperform | Get Alert |
| 11/19/2024 | BNTX | Buy Now | BioNTech | $98.96 | 26.31% | Cory Kasimov70% | $110 → $125 | Upgrade | In-Line → Outperform | Get Alert |
| 10/30/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 46.75% | Cory Kasimov70% | $115 → $105 | Maintains | Outperform | Get Alert |
| 10/24/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 76.7% | Cory Kasimov70% | $1250 → $1175 | Maintains | Outperform | Get Alert |
| 08/07/2024 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 42.86% | Cory Kasimov70% | $50 → $45 | Maintains | Outperform | Get Alert |
| 08/06/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 60.73% | Cory Kasimov70% | $113 → $115 | Maintains | Outperform | Get Alert |
| 06/27/2024 | MRNA | Buy Now | Moderna | $33.73 | 255.77% | Cory Kasimov70% | $120 → $120 | Maintains | In-Line | Get Alert |
| 05/14/2024 | ACLX | Buy Now | Arcellx | $69.87 | 21.65% | Cory Kasimov70% | → $85 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 58.73% | Cory Kasimov70% | → $50 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 59.53% | Cory Kasimov70% | → $175 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | MRNA | Buy Now | Moderna | $33.73 | 255.77% | Cory Kasimov70% | → $120 | Initiates | → In-Line | Get Alert |
| 05/14/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 72.94% | Cory Kasimov70% | → $1150 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 57.93% | Cory Kasimov70% | → $113 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | BNTX | Buy Now | BioNTech | $98.96 | 1.05% | Cory Kasimov70% | → $100 | Initiates | → In-Line | Get Alert |
| 02/27/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 126.45% | Cory Kasimov70% | $84 → $88 | Maintains | Overweight | Get Alert |
| 06/05/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | Cory Kasimov70% | $260 → $250 | Maintains | Overweight | Get Alert |
| 02/11/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 239.68% | Cory Kasimov70% | → $132 | Upgrade | Neutral → Overweight | Get Alert |
| 01/05/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Cory Kasimov70% | → $50 | Initiates | → Overweight | Get Alert |
| 12/21/2021 | BIIB | Buy Now | Biogen | $143.09 | 92.89% | Cory Kasimov70% | $324 → $276 | Maintains | Neutral | Get Alert |
| 09/30/2021 | KRTX | Buy Now | Karuna Therapeutics | — | — | Cory Kasimov70% | → $162 | Initiates | → Overweight | Get Alert |
| 03/01/2021 | SANA | Buy Now | Sana Biotechnology | $2.30 | 1421.74% | Cory Kasimov70% | → $35 | Initiates | → Neutral | Get Alert |
| 02/17/2021 | BLUE | Buy Now | bluebird bio | $3.94 | 889.85% | Cory Kasimov70% | $1520 → $780 | Downgrade | Overweight → Neutral | Get Alert |
| 02/12/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 324.6% | Cory Kasimov70% | → $165 | Downgrade | Overweight → Neutral | Get Alert |
| 07/29/2020 | AMGN | Buy Now | Amgen | $318.65 | -27.19% | Cory Kasimov70% | $225 → $232 | Maintains | Neutral | Get Alert |
| 07/20/2020 | MRNA | Buy Now | Moderna | $33.73 | 163.86% | Cory Kasimov70% | $60 → $89 | Downgrade | Overweight → Neutral | Get Alert |
| 06/18/2020 | AMGN | Buy Now | Amgen | $318.65 | -29.39% | Cory Kasimov70% | $219 → $225 | Maintains | Neutral | Get Alert |
| 05/06/2020 | INCY | Buy Now | Incyte | $60.00 | — | Cory Kasimov70% | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/01/2020 | GILD | Buy Now | Gilead Sciences | $107.30 | — | Cory Kasimov70% | — | Downgrade | Overweight → Neutral | Get Alert |
| 04/17/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Cory Kasimov70% | $168 → $163 | Maintains | Overweight | Get Alert |
| 04/15/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -35.48% | Cory Kasimov70% | $375 → $429 | Maintains | Neutral | Get Alert |
| 03/18/2020 | BNTX | Buy Now | BioNTech | $98.96 | -66.65% | Cory Kasimov70% | → $33 | Downgrade | Overweight → Neutral | Get Alert |
| 02/14/2020 | ALKS | Buy Now | Alkermes | $34.32 | -38.81% | Cory Kasimov70% | $25 → $21 | Downgrade | Overweight → Neutral | Get Alert |
| 11/04/2019 | BNTX | Buy Now | BioNTech | $98.96 | -76.76% | Cory Kasimov70% | → $23 | Initiates | → Overweight | Get Alert |
| 10/23/2019 | BIIB | Buy Now | Biogen | $143.09 | 81.7% | Cory Kasimov70% | $244 → $260 | Maintains | Neutral | Get Alert |
| 08/29/2019 | AMGN | Buy Now | Amgen | $318.65 | -37.86% | Cory Kasimov70% | $191 → $198 | Maintains | Neutral | Get Alert |
| 07/31/2019 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Cory Kasimov70% | — | Initiates | → Overweight | Get Alert |
| 01/02/2019 | MRNA | Buy Now | Moderna | $33.73 | -34.78% | Cory Kasimov70% | → $22 | Initiates | → Overweight | Get Alert |
| 11/14/2018 | JNCE | Buy Now | Jounce Therapeutics | — | — | Cory Kasimov70% | — | Downgrade | Neutral → Underweight | Get Alert |
| 11/02/2018 | PBYI | Buy Now | Puma Biotechnology | $3.34 | 588.62% | Cory Kasimov70% | $83 → $23 | Maintains | Underweight | Get Alert |
| 11/02/2018 | PBYI | Buy Now | Puma Biotechnology | $3.34 | 588.62% | Cory Kasimov70% | $83 → $23 | Downgrade | Overweight → Underweight | Get Alert |
| 10/31/2018 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | $71 → $16 | Downgrade | Overweight → Neutral | Get Alert |
| 10/24/2018 | BIIB | Buy Now | Biogen | $143.09 | 204.7% | Cory Kasimov70% | $445 → $436 | Maintains | Overweight | Get Alert |
| 08/10/2018 | JNCE | Buy Now | Jounce Therapeutics | — | — | Cory Kasimov70% | $12 → $10 | Maintains | Neutral | Get Alert |
| 08/10/2018 | PBYI | Buy Now | Puma Biotechnology | $3.34 | 2385.03% | Cory Kasimov70% | $80 → $83 | Maintains | Overweight | Get Alert |
| 07/27/2018 | AMGN | Buy Now | Amgen | $318.65 | -39.75% | Cory Kasimov70% | $191 → $192 | Maintains | Neutral | Get Alert |
| 06/04/2018 | JNCE | Buy Now | Jounce Therapeutics | — | — | Cory Kasimov70% | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/31/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 85.88% | Cory Kasimov70% | $127 → $133 | Maintains | Overweight | Get Alert |
| 05/01/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | Cory Kasimov70% | $60 → $63 | Maintains | Neutral | Get Alert |
| 04/24/2018 | INCY | Buy Now | Incyte | $60.00 | 46.67% | Cory Kasimov70% | $96 → $88 | Maintains | Overweight | Get Alert |
| 04/09/2018 | INCY | Buy Now | Incyte | $60.00 | 60% | Cory Kasimov70% | $149 → $96 | Maintains | Overweight | Get Alert |
| 03/21/2018 | CELG | Buy Now | Celgene | — | — | Cory Kasimov70% | → $110 | Reinstates | → Overweight | Get Alert |
| 02/21/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 69.84% | Cory Kasimov70% | $68 → $66 | Maintains | Overweight | Get Alert |
| 02/14/2018 | LIFE | Buy Now | aTyr Pharma | — | — | Cory Kasimov70% | — | Downgrade | Neutral → Underweight | Get Alert |
| 02/14/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | Cory Kasimov70% | — | Downgrade | Overweight → Neutral | Get Alert |
| 02/14/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | Cory Kasimov70% | $62 → $60 | Maintains | Neutral | Get Alert |
| 02/14/2018 | LXRX | Buy Now | Lexicon Pharmaceuticals | $0.36 | 2701.12% | Cory Kasimov70% | $15 → $10 | Maintains | Underweight | Get Alert |
| 02/14/2018 | DVAX | Buy Now | Dynavax Technologies | $13.90 | 79.86% | Cory Kasimov70% | $310 → $250 | Maintains | Neutral | Get Alert |
| 01/24/2018 | AMGN | Buy Now | Amgen | $318.65 | -40.69% | Cory Kasimov70% | $184 → $189 | Maintains | Neutral | Get Alert |
| 01/24/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -31.27% | Cory Kasimov70% | $455 → $457 | Maintains | Neutral | Get Alert |
| 01/24/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 80.29% | Cory Kasimov70% | $131 → $129 | Maintains | Outperform | Get Alert |
| 01/24/2018 | PBYI | Buy Now | Puma Biotechnology | $3.34 | 2624.55% | Cory Kasimov70% | $138 → $91 | Maintains | Overweight | Get Alert |
| 06/19/2017 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | — | Upgrade | Sell → Neutral | Get Alert |
| 05/17/2017 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | — | Upgrade | Neutral → Overweight | Get Alert |
| 02/21/2017 | JNCE | Buy Now | Jounce Therapeutics | — | — | Cory Kasimov70% | → $28 | Initiates | → Overweight | Get Alert |
| 02/03/2017 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | → $36 | Downgrade | Neutral → Sell | Get Alert |
| 12/20/2016 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | → $36 | Upgrade | Sell → Neutral | Get Alert |
| 12/14/2016 | LIFE | Buy Now | aTyr Pharma | — | — | Cory Kasimov70% | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/25/2016 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | — | Initiates | → Sell | Get Alert |
| 10/21/2016 | ALKS | Buy Now | Alkermes | $34.32 | — | Cory Kasimov70% | — | Upgrade | Neutral → Overweight | Get Alert |
| 08/11/2016 | LIFE | Buy Now | aTyr Pharma | — | — | Cory Kasimov70% | $210 → $140 | Maintains | Overweight | Get Alert |
| 08/05/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 77.5% | Cory Kasimov70% | $120 → $127 | Maintains | Overweight | Get Alert |
| 04/13/2016 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | $42 → $15 | Downgrade | Overweight → Neutral | Get Alert |
| 03/29/2016 | PBYI | Buy Now | Puma Biotechnology | $3.34 | 2564.67% | Cory Kasimov70% | $105 → $89 | Maintains | Overweight | Get Alert |
| 02/29/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 118.73% | Cory Kasimov70% | $125 → $85 | Maintains | Market Outperform | Get Alert |
| 02/10/2016 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -28.27% | Cory Kasimov70% | $537 → $477 | Maintains | Neutral | Get Alert |
| 01/28/2016 | INCY | Buy Now | Incyte | $60.00 | 91.67% | Cory Kasimov70% | $125 → $115 | Maintains | Overweight | Get Alert |
| 10/01/2015 | CELG | Buy Now | Celgene | — | — | Cory Kasimov70% | → $152 | Upgrade | Neutral → Overweight | Get Alert |
| 08/27/2015 | PBYI | Buy Now | Puma Biotechnology | $3.34 | 3552.69% | Cory Kasimov70% | → $122 | Initiates | → Overweight | Get Alert |
| 08/07/2015 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | $92 → $103 | Maintains | Overweight | Get Alert |
| 06/18/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 111.04% | Cory Kasimov70% | $140 → $151 | Maintains | Overweight | Get Alert |
| 06/15/2015 | BLUE | Buy Now | bluebird bio | $3.94 | 6092.89% | Cory Kasimov70% | $4000 → $4880 | Maintains | Overweight | Get Alert |
| 06/01/2015 | LIFE | Buy Now | aTyr Pharma | — | — | Cory Kasimov70% | — | Initiates | → Overweight | Get Alert |
| 05/27/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 95.67% | Cory Kasimov70% | $125 → $140 | Maintains | Overweight | Get Alert |
| 03/19/2015 | ONCE | Buy Now | Spark Therapeutics | — | — | Cory Kasimov70% | $74 → $82 | Maintains | Overweight | Get Alert |
| 02/26/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 67.71% | Cory Kasimov70% | $110 → $120 | Maintains | Overweight | Get Alert |
| 02/26/2015 | BLUE | Buy Now | bluebird bio | $3.94 | 2869.54% | Cory Kasimov70% | $2060 → $2340 | Maintains | Overweight | Get Alert |
| 02/24/2015 | ONCE | Buy Now | Spark Therapeutics | — | — | Cory Kasimov70% | → $74 | Initiates | → Overweight | Get Alert |
| 02/10/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 53.74% | Cory Kasimov70% | $101 → $110 | Maintains | Overweight | Get Alert |
| 12/11/2014 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 41.16% | Cory Kasimov70% | $90 → $101 | Maintains | Overweight | Get Alert |
| 12/05/2014 | GILD | Buy Now | Gilead Sciences | $107.30 | 12.77% | Cory Kasimov70% | $110 → $121 | Maintains | Overweight | Get Alert |
| 08/08/2014 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | $101 → $92 | Maintains | Overweight | Get Alert |
| 07/25/2014 | CELG | Buy Now | Celgene | — | — | Cory Kasimov70% | $85 → $95 | Maintains | Neutral | Get Alert |
| 07/24/2014 | GILD | Buy Now | Gilead Sciences | $107.30 | 2.52% | Cory Kasimov70% | $100 → $110 | Maintains | Overweight | Get Alert |
| 06/18/2014 | BLUE | Buy Now | bluebird bio | $3.94 | 1245.18% | Cory Kasimov70% | $880 → $1060 | Maintains | Overweight | Get Alert |
| 05/29/2014 | BIIB | Buy Now | Biogen | $143.09 | 162.07% | Cory Kasimov70% | $300 → $375 | Upgrade | Neutral → Overweight | Get Alert |
| 05/29/2014 | CELG | Buy Now | Celgene | — | — | Cory Kasimov70% | $90 → $85 | Downgrade | Overweight → Neutral | Get Alert |
| 02/25/2014 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 69.84% | Cory Kasimov70% | → $66 | Initiates | → Overweight | Get Alert |
| 12/18/2013 | GILD | Buy Now | Gilead Sciences | $107.30 | -6.8% | Cory Kasimov70% | $85 → $100 | Maintains | Overweight | Get Alert |
| 07/15/2013 | BLUE | Buy Now | bluebird bio | $3.94 | 1016.75% | Cory Kasimov70% | → $880 | Initiates | → Overweight | Get Alert |
| 05/07/2013 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | $33 → $45 | Maintains | Overweight | Get Alert |
| 03/11/2013 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov70% | $18 → $33 | Maintains | Overweight | Get Alert |
| 11/01/2012 | ALKS | Buy Now | Alkermes | $34.32 | -24.24% | Cory Kasimov70% | $25 → $26 | Maintains | Overweight | Get Alert |
| 09/27/2012 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | -30.12% | Cory Kasimov70% | $47 → $50 | Maintains | Overweight | Get Alert |
| 09/17/2012 | GILD | Buy Now | Gilead Sciences | $107.30 | -30.1% | Cory Kasimov70% | $35 → $37.5 | Maintains | Overweight | Get Alert |
| 07/11/2012 | LIFE | Buy Now | aTyr Pharma | — | — | Cory Kasimov70% | $728 → $644 | Downgrade | Overweight → Neutral | Get Alert |
| 05/31/2012 | ALKS | Buy Now | Alkermes | $34.32 | -32.98% | Cory Kasimov70% | $24 → $23 | Maintains | Overweight | Get Alert |
| 04/26/2012 | INCY | Buy Now | Incyte Genomics | $60.00 | -58.33% | Cory Kasimov70% | $23 → $25 | Maintains | Overweight | Get Alert |
